[1]OrganicLetters,2010,vol.12,#19,p.4232-4235
[1]GreenChemistry,2012,vol.14,#2,p.326-329
[1]TetrahedronLetters,2008,vol.49,#18,p.3004-3008
[2]TetrahedronLetters,2008,vol.49,#18,p.3004-3008
[1]TetrahedronLetters,1994,vol.35,#15,p.2401-2404
[1]JournalofOrganicChemistry,1990,vol.55,p.1676-1679
[1]TetrahedronLetters,1994,vol.35,p.2401-2404
40138-16-7
82565-68-2
118-91-2
[1]BioorganicandMedicinalChemistryLetters,2002,vol.12,p.2913-2917
[1]Chen,Wenteng;Liu,Shuangrong;Liu,Xingyu;Pan,Youlu;Shao,Jiaan[BioorganicandMedicinalChemistry,2020,vol.28,#19]
[2]CurrentPatentAssignee:SANOFI-US2012/277220,2012,A1Locationinpatent:Page/Pagecolumn18-19
[3]CurrentPatentAssignee:SINOBIOPHARMACEUTICALLIMITED-CN106905245,2017,ALocationinpatent:Paragraph0344;0345;0346;0347;0348
[4]Locationinpatent:schemeortableFinlay,M.RaymondV.;Acton,DavidG.;Andrews,DavidM.;Barker,AndrewJ.;Dennis,Michael;Fisher,Eric;Graham,MarkA.;Green,CliveP.;Heaton,DavidW.;Karoutchi,Galith;Loddick,SarahA.;Morgentin,Remy;Roberts,Andrew;Tucker,JulieA.;Weir,HazelM.[BioorganicandMedicinalChemistryLetters,2008,vol.18,#15,p.4442-4446]
[5]CurrentPatentAssignee:THERAVANCEBIOPHARMA,INC.-WO2021/108803,2021,A1Locationinpatent:Page/Pagecolumn53-54
[6]CurrentPatentAssignee:EVOTECAG-WO2008/122787,2008,A1Locationinpatent:Page/Pagecolumn81
[7]VanderWel,ScottN.;Harvey,PatriciaJ.;McNamara,DennisJ.;Repine,JosephT.;Keller,PaulR.;QuinIII,John;Booth,R.John;Elliott,WilliamL.;Dobrusin,EllenM.;Fry,DavidW.;Toogood,PeterL.[JournalofMedicinalChemistry,2005,vol.48,#7,p.2371-2387]
[8]Locationinpatent:schemeortableWang,Shudong;Midgley,CarolA.;Scaërou,Frederic;Grabarek,JoannaB.;Griffiths,Gary;Jackson,Wayne;Kontopidis,George;McClue,StevenJ.;McInnes,Campbell;Meades,Christopher;Mezna,Mokdad;Plater,Andy;Stuart,Iain;Thomas,MarkP.;Wood,Gavin;Clarke,RosemaryG.;Blake,DavidG.;Zheleva,DaniellaI.;Lane,DavidP.;Jackson,RobertC.;Glover,DavidM.;Fischer,PeterM.[JournalofMedicinalChemistry,2010,vol.53,#11,p.4367-4378]
[9]Chen,Lijuan;Cui,Xue;Pei,Heying;Qi,Wenyan;Shi,Mingsong;Tang,Minghai;Xu,Yaohui;Yang,Linyu;Yang,Tao;Yang,Zhuang;Zhang,Wanhua;Zhu,Zejiang;xie,Lixin[JournalofMedicinalChemistry,2022,vol.65,#4,p.3151-3172]
[1]BioorganicandMedicinalChemistry,2008,vol.16,p.9911-9924
[2]BioorganicandMedicinalChemistryLetters,2006,vol.16,p.4063-4067
Title: Strategies to prevent N-acetyltransferase-mediated metabolism in a series of piperazine-containing pyrazalopyrimidine compounds.
Journal: Xenobiotica; the fate of foreign compounds in biological systems 20080901
Title: Process development and large-scale synthesis of NK1 antagonist.
Journal: Chemical & pharmaceutical bulletin 20080201
Title: Design, synthesis, and evaluation of novel 2-substituted-4-aryl-6,7,8,9-tetrahydro-5H-pyrimido[4,5-b][1,5]oxazocin-5-ones as NK1 antagonists.
Journal: Bioorganic & medicinal chemistry 20051015
